GGrantIndex
Sort

146,196 grants matching diabetes

Testing combinations of population interventions to encourage healthy eating

$754,951
Dean Schillinger · University Of California, San Francisco · R01 · FY2021 · DK

SPREAD-NET: PRactices Enabling Adapting and Disseminating in the safety NET

$754,935
Rachel Gold · Kaiser Foundation Research Institute · R01 · FY2014 · HL

Fluid Therapy and Cerebral Injury in Pediatric Diabetic Ketoacidosis

$754,875
Nathan Kuppermann · University Of California At Davis · R01 · FY2010 · HD

Duke-UNC-Stanford AMDC Unit

$754,857
Duke University · U01 · FY2004 · HL

Physical Activity and Sedentary Behavior Change; Impact on Lifestyle Intervention Effects for Diabetes Translation

$754,826
Andrea M Kriska · University Of Pittsburgh At Pittsburgh · R18 · FY2014 · DK

eMERGE Phase IV Clinical Center at Mass General Brigham

$754,765
Elizabeth W Karlson · Brigham And Women'S Hospital · U01 · FY2024 · HG

Transforming Growth Factor Beta Superfamily Signaling in Pancreas Biology

$754,756
Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Center

$754,731
John M Lachin · George Washington University · U01 · FY2017 · DK

Assessment of Reconstructive Surgical Flaps Using Spatially Resolved Tissue Oxima

$754,697
David John Cuccia · Modulated Imaging, Inc. · R42 · FY2011 · GM

Functional interaction of transcriptional regulators in endocrine lineage specification

$754,659
Doris A. Stoffers · University Of Pennsylvania · R01 · FY2023 · DK

Natural History of Prediabetic Autoimmunity

$754,630
University Of Colorado Denver · R37 · FY2001 · DK

PRIMARY PREVENTION TRIAL (DPT-2)

$754,609
University Of New Mexico · U01 · FY2000 · DK

Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups

$754,605
Sarah Banks · University Of California, San Diego · R01 · FY2025 · AG

Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)

$754,595
Ashley Nicole Battarbee · University Of Alabama At Birmingham · R01 · FY2025 · HD

Postdoctoral Training in Cardiovascular Disease

$754,581
Mark A Hardy · Columbia University Health Sciences · T32 · FY2019 · HL

Sleep Disturbance and risk for adverse pregnancy outcomes

$754,558
Phyllis C Zee · Northwestern University At Chicago · R01 · FY2011 · HL

Chemical Genetic Elucidation of Histone Acetyltransferase Signaling Networks

$754,556
Hans Luecke · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Real-Time Heteroplasmy Analysis on Microarrays

$754,456
Alexander Michael Chagovetz · Salt Lake City Bioscience, Inc. · R44 · FY2010 · GM

Addressing Marshallese Immigrant Barriers to Diabetes Self-Management through Family DSMES

$754,414
Pearl McElfish · Univ Of Arkansas For Med Scis · R01 · FY2019 · MD

The SREBP Pathway and Cellular Cholesterol Homeostasis

$754,413
Michael S Brown · Ut Southwestern Medical Center · P01 · FY2010 · HL

Para-Vascular Basis of Small Vessel Disease

$754,355
Maiken Nedergaard · University Of Rochester · R01 · FY2020 · NS

Evaluation of a Long-Term Self-Management Support System

$754,319
Robert Robert M Anderson Anderson · University Of Michigan At Ann Arbor · R18 · FY2006 · DK

Addressing Ableism through Accommodations for Blindness and Low vision to achieve Equity (AAABLE) in Healthcare

$754,289
John Ross Rizzo · New York University School Of Medicine · R01 · FY2024 · EY

CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD

$754,268
Yong Chen · University Of Pennsylvania · R56 · FY2022 · AG

Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance

$754,229
Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI